Literature DB >> 15526223

Intramedullary spinal cord metastases: diagnosis and treatment - an illustrated review.

M Kalayci1, F Cağavi, S Gül, S Yenidünya, B Açikgöz.   

Abstract

BACKGROUND: Intramedullary spinal cord metastases (ISCM) are rare but, with increasing use of magnetic resonance imaging (MRI) are being encountered with increasing frequency. Optimum treatment remains controversial. On the basis of a review of previous reports and experience with a patient with an ISCM from a large cell lung cancer, we propose practical diagnostic and therapeutic approaches.
FINDINGS: We found 284 patients who had an Intramedullary spinal cord metastasis reported in English literature up to February 2004. 32 had been treated surgically. The mean survival in these patients was two times longer than in those treated by a conservative approach. Improvement and prolonged survival occurred in patient we treated by microsurgical dissection of the metastasis.
CONCLUSION: Early diagnosis and early surgical resection can result in improvement in neurological deficits and in the quality of life of patients with a Intramedullary spinal cord metastasis.

Entities:  

Mesh:

Year:  2004        PMID: 15526223     DOI: 10.1007/s00701-004-0386-1

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  37 in total

1.  Intramedullary spinal cord metastasis from rectal cancer.

Authors:  Kyung Ho Yang; Hye Ran Lee; Seong Yoon Yi; Joo Hyuk Jung; Seung Hee Kang; Pyong Hwa Choi
Journal:  Ann Coloproctol       Date:  2014-10-28

2.  Intramedullary spinal cord metastasis from colonic carcinoma presenting as Brown-Séquard syndrome: a case report.

Authors:  Mohammed A Kaballo; Darren D Brennan; Mazen El Bassiouni; Stephen J Skehan; Rajnish K Gupta
Journal:  J Med Case Rep       Date:  2011-08-02

3.  Central nervous system myelomatosis with optic neuropathy and intramedullary spinal cord compression responding to radiation therapy.

Authors:  Jenny M Riley; James K Russo; Allison Shipp; Mariam Alsharif; Joseph M Jenrette
Journal:  Jpn J Radiol       Date:  2011-09-01       Impact factor: 2.374

4.  Intramedullary spinal cord metastasis from colon cancer: analysis of 19 reported cases.

Authors:  Tai-Hsin Tsai; I-Cheng Lin; Pei-Chen Lin; Chieh-Hsin Wu; Chih-Lung Lin; Yu-Feng Su
Journal:  Spinal Cord Ser Cases       Date:  2016-01-07

Review 5.  Conus medullaris metastasis in breast cancer: report of a case and a review of the literature.

Authors:  Kao-Chih Hsu; Tsung-Ying Li; Heng-Yi Chu; Liang-Cheng Chen; Shin-Tsu Chang; Yung-Tsan Wu
Journal:  Surg Today       Date:  2012-08-08       Impact factor: 2.549

Review 6.  CNS complications of breast cancer: current and emerging treatment options.

Authors:  Evert C A Kaal; Charles J Vecht
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Complete response of 7 years' duration after chemoradiotherapy followed by gefitinib in a patient with intramedullary spinal cord metastasis from lung adenocarcinoma.

Authors:  Yoshinobu Hata; Yujiro Takai; Hiroshi Takahashi; Keigo Takagi; Kazutoshi Isobe; Chikako Hasegawa; Kazutoshi Shibuya; Hidenori Goto; Kazuyoshi Tamaki; Fumitomo Sato; Hajime Otsuka
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

8.  A case of long-term survival after multimodal local treatments of intramedullary spinal cord metastasis of squamous cell lung cancer.

Authors:  Shojiro Minomo; Akihiro Tokoro; Tomoki Utsumi; Masahiro Ishihara; Masanori Akira; Shinji Atagi
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

9.  Rim and flame signs: postgadolinium MRI findings specific for non-CNS intramedullary spinal cord metastases.

Authors:  J B Rykken; F E Diehn; C H Hunt; L J Eckel; K M Schwartz; T J Kaufmann; J T Wald; C Giannini; C P Wood
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-18       Impact factor: 3.825

10.  Intradural intramedullary spinal cord metastasis due to mesothelioma.

Authors:  Marc C Chamberlain; Keith D Eaton; James R Fink; Trent Tredway
Journal:  J Neurooncol       Date:  2009-08-20       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.